US Federal Reserve boss Kevin Warsh said Friday the global economy had shown unexpected resilience against strong economic ...
Trisura Group has delivered a 33.3% share price gain over the past three years, which puts a spotlight on whether the current ...
Pets at Home Group has delivered a mixed ride for shareholders, with a recent rebound sitting alongside weak longer term ...
Home BancShares entered this Q3 2026 report with a value label on the stock and a share price that had drifted over the past ...
Ströer SE KGaA has edged higher in recent weeks, yet the longer track record for the stock raises a simple question: Is today ...
KOMEDA Holdings came into this earnings print with the stock at ¥2,869, roughly flat over the past month and only a small ...
Côte d'Ivoire-based real estate technology platform introduces professional onboarding through PROPESIA Market, supporting digital property listings and portfolio management.ABIDJAN, CI / ACCESS ...
Gene (NASDAQ:ENGN) used a company webinar to outline preclinical findings for its investigational non-viral gene therapy, detalimogene voraplasmid, used with a polidocanol surfactant bladder rinse, wh ...
Alcoa Corp (AA) delivered $483 million in net income and $472 million in free cash flow while advancing the AliGroup acquisition and Massena East asset monetization.
Basler AG (BSLAF) posted 60% booking growth and a 51.6% gross margin in H1 2026, prompting a full-year revenue guidance hike to EUR270-290 million even as a Japan earthquake threatens sensor supplies.
Anthropic’s Q3 revenue rose 45% sequentially, compared to 147% growth in the preceding quarter, according to Anthropic’s ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Enspryng® (satralizumab-mwge) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results